Celsius Holdings, Inc.
27.64USD
-1.9200 (-6.50%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.35▼ | $0.44 | 0 | 16 |
| Next quarter | $0.32▼ | $0.36 | 1 | 15 |
| Current year | $1.44▼ | $1.62 | 0 | 20 |
| Next year | $1.75▼ | $2.03 | 0 | 20 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.42 | $0.36 | -0.06 (-13.9%) |
| 2026-03-31 | $0.29 | $0.41 | +0.12 (+40.0%) |
| 2025-12-31 | $0.19 | $0.26 | +0.07 (+36.9%) |
| 2025-09-30 | $0.28 | $0.42 | +0.14 (+52.1%) |
225 ratings from 28 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Stephens & Co. | Maintained | Overweight | $65 $50 | Aug 10, 2026 |
| Maxim Group | Downgraded from Buy | Hold | — | Aug 8, 2026 |
| UBS | Maintained | Buy | $50 $44 | Aug 7, 2026 |
| Citigroup | Maintained | Buy | $50 $40 | Aug 7, 2026 |
| Morgan Stanley | Maintained | Overweight | $48 $42 | Aug 7, 2026 |
| JP Morgan | Maintained | Overweight | $56 $52 | Aug 7, 2026 |
| Bernstein | Downgraded from Outperform | Market Perform | $44 $26 | Aug 7, 2026 |
| Piper Sandler | Maintained | Overweight | $49 $36 | Aug 7, 2026 |
| Needham | Maintained | Buy | $55 $35 | Aug 6, 2026 |
| Stifel | Maintained | Buy | $62 $45 | Jul 16, 2026 |
| Citigroup | Maintained | Buy | $60 $50 | Jul 14, 2026 |
| Needham | Maintained | Buy | $75 $55 | Jul 9, 2026 |
| UBS | Maintained | Buy | $55 $50 | Jun 30, 2026 |
| Roth Capital | Maintained | Buy | $65 $57 | Jun 25, 2026 |
| B of A Securities | Maintained | Buy | $55 $45 | Jun 24, 2026 |
| Morgan Stanley | Maintained | Overweight | $55 $48 | Jun 23, 2026 |
| Bernstein | Initiated | Outperform | $44 | Jun 11, 2026 |
| BNP Paribas | Maintained | Outperform | $70 $57 | May 26, 2026 |
| JP Morgan | Maintained | Overweight | $67 $70 | May 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $64 $55 | May 8, 2026 |
| Rothschild & Co | Initiated | Neutral | $47 | May 6, 2026 |
| JP Morgan | Maintained | Overweight | $77 $67 | May 4, 2026 |
| Citigroup | Maintained | Buy | $65 $60 | Apr 15, 2026 |
| UBS | Maintained | Buy | $72 $62 | Apr 7, 2026 |
| Deutsche Bank | Upgraded from Hold | Buy | $56 $44 | Mar 30, 2026 |
63 filings from 19 insiders · 0 buy / 0 sell over 6m
Officers and directors of CELH, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| PREVIN FLETCHER FDirector | Grant | 3.8k | $27.77 | $106k | Aug 7, 2026 |
| KRAVITZ HALDirector | Buy | 8.4k | $29.73 | $250k | May 22, 2026 |
| FIELDLY JOHN ERICKChief Executive Officer | Buy | 8.5k | $29.36 | $249k | May 22, 2026 |
| HANSON ERICPresident | Buy | 7.5k | $29.04 | $218k | May 21, 2026 |
| LAM THI TUYET TRINHOfficer | Grant | 9.2k | — | — | Mar 2, 2026 |
| RUSSELL JOYCEDirector | Sell | 2.9k | $51.31 | $148k | Mar 2, 2026 |
| DESANTIS DAMONDirector | Grant | 2.6k | — | — | Feb 27, 2026 |
| MILLER CHERYL SDirector | Grant | 2.6k | — | — | Feb 27, 2026 |
| KRAVITZ HALDirector | Grant | 2.6k | — | — | Feb 27, 2026 |
| CASTALDO NICHOLASDirector | Grantindirect | 2.6k | — | — | Feb 27, 2026 |
| FIELDLY JOHN ERICKChief Executive Officer | Grant | 42.0k | — | — | Feb 27, 2026 |
| LEVY CAROLINE SDirector | Grant | 2.6k | — | — | Feb 27, 2026 |
| RUSSELL JOYCEDirector | Grant | 2.6k | — | — | Feb 27, 2026 |
| LANGHANS JARRODChief Financial Officer | Grant | 15.0k | — | — | Feb 27, 2026 |
| STOREY PAUL HOfficer | Grant | 8.8k | — | — | Feb 27, 2026 |
| MATTESSICH RICHARD STEPHENOfficer | Grant | 8.8k | — | — | Feb 27, 2026 |
| MELOTTE HANS MJDirector | Grant | 2.6k | — | — | Feb 27, 2026 |
| HANSON ERICPresident | Grant | 10.7k | — | — | Feb 27, 2026 |
| FIELDLY JOHN ERICKChief Executive Officer | Grant | 18.6k | — | — | Dec 9, 2025 |
| LANGHANS JARRODChief Financial Officer | Grant | 11.1k | — | — | Dec 9, 2025 |
No analyst notes on CELH yet.
Analyst Ratings
21 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 6 | 12 | 6 | 0 | 0 | Buy2.00 |
| 1 mo ago | 5 | 12 | 7 | 0 | 0 | Buy2.08 |
| 2 mo ago | 7 | 13 | 3 | 0 | 0 | Buy1.83 |
| 3 mo ago | 7 | 13 | 3 | 0 | 0 | Buy1.83 |